Výsledky vyhledávání - "Annenienke C van de Ven"

Akademický článek

Venous thromboembolism in patients with adrenocortical carcinoma after surgery

Autor: Jülide Durmuşoğlu, Henri J L M Timmers, Pepijn van Houten, Hans F Langenhuijsen, Ad R M M Hermus, Annenienke C van de Ven

Publikováno v: Endocrine Connections, Vol 9, Iss 9, Pp 874-881 (2020)

Background: Adrenocortical carcinoma is a rare malignancy with a poor prognosis. We hypothesized that patients with adrenocortical carcinoma are at high risk for venous thromboembolism, given the numerous risk factors such as malignancy, abdominal su

Externí odkaz: https://doaj.org/article/d365cfdfd30b43149d28caa43ae1e18f

Zobrazit plný text záznamu

Akademický článek

A multidisciplinary care pathway improves quality of life and reduces pain in patients with fibrous dysplasia/McCune-Albright syndrome: a multicenter prospective observational study

Autor: Maartje E. Meier, Marlous Hagelstein-Rotman, Annenienke C. van de Ven, Ingrid C. M. Van der Geest, Olav Donker, Sarina E. C. Pichardo, Petra C. E. Hissink Muller, Stijn W. van der Meeren, Desirée M. J. Dorleijn, Elizabeth M. Winter, Michiel A. J. van de Sande, Natasha M. Appelman-Dijkstra

Publikováno v: Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-12 (2022)

Abstract Background Fibrous dysplasia/McCune-Albright syndrome (FD/MAS) may cause pain, impaired ambulation and decreased quality of life (QoL). International guidelines advocate management of FD/MAS in a tertiary multidisciplinary care pathway, but

Externí odkaz: https://doaj.org/article/8c47bc66e2f94089946b920659a3c183

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Concomitant systemic inflammation and cellular immunosuppression in patients with Cushing's syndrome

Autor: Pepijn van Houten, Chunying Peng, Martin Jaeger, Antonius E. van Herwaarden, Mihai G. Netea, Annenienke C. van de Ven, Romana T. Netea‐Maier

Publikováno v: Clinical and Translational Medicine, Vol 13, Iss 7, Pp n/a-n/a (2023)

Externí odkaz: https://doaj.org/article/530ffee608c044b294a7f95b232e1e9b

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

The PRolaCT studies — a study protocol for a combined randomised clinical trial and observational cohort study design in prolactinoma

Publikováno v: Trials, Vol 22, Iss 1, Pp 1-13 (2021)

Abstract Background First-line treatment for prolactinomas is a medical treatment with dopamine agonists (DAs), which effectively control hyperprolactinaemia in most patients, although post-withdrawal remission rates are approximately 34%. Therefore,

Externí odkaz: https://doaj.org/article/1666f094fa3f43fd86206fba8afb06e3

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice

Autor: Dirk-Jan van Beek, Carolina R. C. Pieterman, Frank J. Wessels, Annenienke C. van de Ven, Wouter W. de Herder, Olaf M. Dekkers, Wouter T. Zandee, Madeleine L. Drent, Peter H. Bisschop, Bas Havekes, Inne H. M. Borel Rinkes, Menno R. Vriens, Gerlof D. Valk

Publikováno v: Frontiers in Endocrinology, Vol 13 (2022)

BackgroundIn multiple endocrine neoplasia type 1 (MEN1), pancreatic neuroendocrine tumors (PanNETs) have a high prevalence and represent the main cause of death. This study aimed to assess the diagnostic accuracy of the currently used conventional pa

Externí odkaz: https://doaj.org/article/b5f2cb52a5b14ddcb3bd263ff995dc58

Zobrazit plný text záznamu

Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients

Autor: Olaf M. Dekkers, Gerlof D. Valk, Wouter T Zandee, M. R. Vriens, Wouter W. de Herder, Bas Havekes, Mirthe J Klein Haneveld, Annenienke C van de Ven, Peter H. Bisschop, Carolina R.C. Pieterman, Madeleine L. Drent, Annemarie A Verrijn Stuart, Mark J C van Treijen, Rachel S van Leeuwaarde

Publikováno v: Journal of Clinical Endocrinology and Metabolism, 106, 3515-3525
Journal of Clinical Endocrinology and Metabolism, 106(12), 3515-3525. Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 106(12), 3515-3525. ENDOCRINE SOC
Journal of Clinical Endocrinology and Metabolism, 106(12), 3515-3525. The Endocrine Society
Journal of Clinical Endocrinology & Metabolism, 106(12), 3515-3525. Oxford University Press
Journal of Clinical Endocrinology and Metabolism, 106, 12, pp. 3515-3525
Journal of clinical endocrinology and metabolism, 106(12), 3515-3525. The Endocrine Society
Klein Haneveld, M J, van Treijen, M J C, Pieterman, C R C, Dekkers, O M, van de Ven, A, de Herder, W W, Zandee, W T, Drent, M L, Bisschop, P H, Havekes, B, Vriens, M R, Verrijn Stuart, A A, Valk, G D & van Leeuwaarde, R S 2021, ' Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients : Results from the DutchMEN Study Group ', Journal of Clinical Endocrinology and Metabolism, vol. 106, no. 12, pp. 3515-3525 . https://doi.org/10.1210/clinem/dgab569

ContextNonfunctioning pancreatic neuroendocrine tumors (NF-pNETs) are highly prevalent and constitute an important cause of mortality in patients with multiple endocrine neoplasia type 1 (MEN1). Still, the optimal age to initiate screening for pNETs

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2ce36b25c25d31e1a499d42dbc31157
https://doi.org/10.1210/clinem/dgab569

Zobrazit plný text záznamu

Well-Differentiated Bronchopulmonary Neuroendocrine Tumors: More Than One Entity

Autor: Gerlof D. Valk, Margot E T Tesselaar, Wouter W. de Herder, Peter H. Bisschop, Wieneke A. Buikhuisen, Bas Havekes, Kim Dijke, Olaf M. Dekkers, Wouter T Zandee, Medard F M van den Broek, Sonja Levy, Rachel S van Leeuwaarde, Koen J. Hartemink, Menno R. Vriens, Madeleine L. Drent, Annenienke C van de Ven

Publikováno v: Journal of thoracic oncology, 16(11), 1810-1820. International Association for the Study of Lung Cancer

Introduction: Until now, well-differentiated bronchopulmonary neuroendocrine tumors (bpNET) occurring either sporadically (sp-bpNET) or in the context of multiple endocrine neoplasia type 1 (MEN1) and diffuse idiopathic pulmonary neuroendocrine cell

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::672e95a51e53f143dabec75e093c3077
http://www.scopus.com/inward/record.url?scp=85113294573&partnerID=8YFLogxK

Zobrazit plný text záznamu

Persistent improvement of bone mineral density up to 20 years after treatment of Cushing's syndrome

Autor: Ad R. M. M. Hermus, Romana T. Netea-Maier, Sean H. P. P. Roerink, Pepijn van Houten, Margreet Wagenmakers, Annenienke C van de Ven

Publikováno v: European Journal of Endocrinology, 185(2), 241-250. Bioscientifica Ltd
European Journal of Endocrinology, 185, 2, pp. 241-250
European Journal of Endocrinology, 185, 241-250

Objective Cushing’s syndrome (CS) is associated with osteoporosis and high fracture risk. Besides male sex, it is unknown which variables influence bone mineral density (BMD) at diagnosis and it is unclear to what extent BMD normalizes during long-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3862f42a3a77f437ed99ec2e29fc309
https://pure.eur.nl/en/publications/354824e1-0996-4640-9c56-61c99eba179b

Zobrazit plný text záznamu

Author response for 'Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study'

Autor: Elizabeth M. Winter, Stance N. Clerkx, Annenienke C van de Ven, Maartje E. Meier, Natasha M. Appelman-Dijkstra, Alberto M Pereira, Michiel A. J. van de Sande

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::74792f158b3eae4192a748e4a2727c8a
https://doi.org/10.1002/jbmr.4380/v2/response1

Zobrazit plný text záznamu

The Management of Neuroendocrine Tumors of the Lung in MEN1: Results From the Dutch MEN1 Study Group

Autor: Peter H. Bisschop, Olaf M. Dekkers, Wieneke A. Buikhuisen, Wenzel M. Hackeng, Madeleine L. Drent, Wouter W. de Herder, Annenienke C van de Ven, Michiel N. Kerstens, Joanne M. de Laat, Lodewijk A.A. Brosens, Rachel S van Leeuwaarde, Gerlof D. Valk, Menno R. Vriens, Medard F M van den Broek, Bas Havekes

Publikováno v: Journal of Clinical Endocrinology & Metabolism, 106(2), E1014-E1027. Oxford University Press
The Journal of clinical endocrinology and metabolism, 106(2), e1014-e1027. Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 106(2), E1014-E1027. The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 106(2), E1014-E1027. ENDOCRINE SOC
Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, 106, 2, pp. e1014-e1027
Journal of clinical endocrinology and metabolism, 106(2), e1014-e1027. The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 106, e1014-e1027
van de Broek, M F M, de Laat, J M, van Leeuwaarde, R S, van de Ven, A C, De Herder, W W, Dekkers, O M, Drent, ML, Kerstens, M N, Bisschop, P H L T, Havekes, B, Hackeng, W M, Brosens, L A A, Vriens, M R, Buikhuisen, W A & Valk, G D 2021, ' The Management of Neuroendocrine Tumors of the Lung in MEN1 : Results From the Dutch MEN1 Study Group ', Journal of Clinical Endocrinology and Metabolism, vol. 106, no. 2, pp. E1014-E1027 . https://doi.org/10.1210/clinem/dgaa800

Introduction Multiple endocrine neoplasia type 1 (MEN1)-related neuroendocrine tumors (NETs) of the lung are mostly indolent, with a good prognosis. Nevertheless, cases of aggressive lung NET do occur, and therefore the management of individual patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3d9987eac83afd274c684e2e77a19ee
https://hdl.handle.net/1887/3563223

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání